NEW YORK, March 14 - Ciphergen Biosystems of Fremont, Calif., said Wednesday it opened a new center in Malvern, Pa., to conduct proteomic research for the company’s customers.

The Biomarker Discovery Center’s first project will entail a clinical stratification pilot study for an unnamed pharmaceutical company. The center will also support the company’s cancer biomarker project with Johns Hopkins School of Medicine. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

American scientists find themselves once again warning the Trump administration not to dismiss science, the New Yorker report.

A new study suggests CRISPR could be used to save coral reefs from dying off, Forbes reports.

Researchers have found that the i-motif shape of DNA previously observed in the lab also exists in human cells, and that it may serve a purpose.

In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.